Tag: Sanofi

James’ office noted that more than 10% of New Yorkers have diabetes,

Dupixent is the only targeted medicine specifically indicated to treat prurigo nodularis in Europe and the U.S.

The products are sold on Amazon.com and other websites as new, the complaint states, "despite the fact that they are used, close-out, liquidation or diverted products."

Regeneron will provide a $900 million upfront payment.

“I do see this campus becoming the pride of Pearl River," said Jamie Schwartz, president of Hudson Valley iCampus.

When a complex process that normally takes seven to nine months is accomplished in only eight days, you can be reasonably certain that something...

Regeneron has started a drug trial to see whether the drug Kevzara that it developed with the French multinational pharmaceutical company Sanofi and has...

Under the new agreement, Paris-based Sanofi would gain sole global rights to Kevzara and sole ex-U.S. rights to Praluent, while Tarrytown’s Regeneron would gain sole U.S. rights to Praluent.

According to the lawsuit, “Zantac’s unprecedented sales were possible only because of a deception perpetrated by the drug’s manufacturers on consumers.”

Judge Richard Andrews’ Aug. 28 ruling overturned portions of a jury verdict in February that found Amgen’s patents on its cholesterol drug Repatha were valid. Regeneron and Sanofi sell rival drug Praluent.

In the U.S., it is indicated for use by prescription to treat moderate-to-severe atopic dermatitis, also known as eczema.

The drug is the first FDA-approved treatment for patients with advanced forms of a skin cancer known as cutaneous squamous cell carcinoma. 

These cancers commonly appear on sun-exposed areas of the body such as the face, ears, neck, lips and backs of the hands.

The European agency will also review the marketing authorization application for cemiplimab, which is used to treat patients with metastatic cutaneous squamous cell carcinoma.

The antibody drug was approved for use in the U,S. last March.